Cellebrite DI Ltd.
CLBT
$13.18
$0.010.08%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -46.08% | -73.63% | -248.96% | |
| Total Depreciation and Amortization | -- | 3.15% | 3.07% | 5.95% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | 42.84% | 64.24% | 169.28% | |
| Change in Net Operating Assets | -- | 211.37% | 50.53% | 9.16% | |
| Cash from Operations | -- | 65.11% | 43.55% | 29.51% | |
| Capital Expenditure | -- | -58.39% | -66.20% | -63.75% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 7.64% | -93.02% | -698.19% | |
| Cash from Investing | -- | 1.67% | -94.24% | -563.15% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | 36.69% | -20.29% | -5.07% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | 36.64% | -20.34% | -5.12% | |
| Foreign Exchange rate Adjustments | -- | 903.97% | 209.69% | -304.92% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | 2,137.99% | -236.22% | -97.90% | |